These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1532133)

  • 1. 3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects.
    Wodarz N; Fritze J; Kornhuber J; Riederer P
    Biol Psychiatry; 1992 Feb; 31(3):291-303. PubMed ID: 1532133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodology of 3H-spiperone binding to lymphocytes.
    Bondy B; Ackenheil M; Engel RR
    J Psychiatr Res; 1990; 24(1):83-92. PubMed ID: 1694898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequestration of [3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker?
    Griffiths RS; Chung-a-on KO; Griffiths KD; Payne JW; Davies JI
    J Psychiatr Res; 1992 Jan; 26(1):77-84. PubMed ID: 1560411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects.
    Wodarz N; Fritze J; Riederer P; Beckmann H
    Biol Psychiatry; 1993 May; 33(10):727-33. PubMed ID: 8353168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding.
    Feenstra A; Coggiano MA; Wyatt RJ
    Psychiatry Res; 1989 Dec; 30(3):259-64. PubMed ID: 2482515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte 3H-spiroperidol binding in schizophrenia: preliminary findings.
    Rotstein E; Mishra RK; Singal DP; Barone D
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):729-32. PubMed ID: 6686701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol.
    Rao ML; Deister A; Roth A
    Pharmacopsychiatry; 1990 Jul; 23(4):176-81. PubMed ID: 2381986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients.
    Grodzicki J; Pardo M; Schved G; Schlosberg A; Fuchs S; Kanety H
    Biol Psychiatry; 1990 Jun; 27(12):1327-30. PubMed ID: 1973057
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of 3H-spiperone by lymphocytes in schizophrenia.
    Itzchaky S; Lerer B; Ebstein RP
    J Psychiatr Res; 1989; 23(3-4):221-7. PubMed ID: 2635219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?
    Bondy B; Ackenheil M; Elbers R; Fröhler M
    Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia.
    Bondy B; Ackenheil M
    J Psychiatr Res; 1987; 21(4):521-9. PubMed ID: 3481637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-spiperone binding to peripheral mononuclear cells in psychiatric in-patients.
    Wodarz N; Fritze J; Riederer P
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Apr; 20(3):459-70. PubMed ID: 8771601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are dopamine receptors present on human lymphocytes?
    Fleminger S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1982 Oct; 34(10):658-63. PubMed ID: 6128389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
    Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
    Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
    Andreasen NC; Carson R; Diksic M; Evans A; Farde L; Gjedde A; Hakim A; Lal S; Nair N; Sedvall G
    Schizophr Bull; 1988; 14(3):471-84. PubMed ID: 2975043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.